Current Technology: Devices Available for Destination Therapy

Cardiology Clinics

Volumn 29, Issue 4, 2011, Pages 499-504

  Takayama, Hiroo ^a   Yang, Jonathan A ^a   Naka, Yoshifumi ^a  

^a Milstein Hospital   (United States)

Author keywords

Destination therapy; HeartMate II; HeartMate XVE; HeartWare

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; POLYURETHAN; TITANIUM; UREA;

AORTA VALVE REGURGITATION; BLEEDING; CENTRIFUGAL PUMP; COGNITION; CONGESTIVE HEART FAILURE; CONTINUOUS FLOW PUMP; DEVICE INFECTION; EQUIPMENT DESIGN; HEART FAILURE; HUMAN; IMPLANTATION; KIDNEY FUNCTION; LEFT VENTRICULAR ASSIST DEVICE; LIVER FUNCTION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PULSATILE FLOW; PULSATILE FLOW PUMP; PUMP; QUALITY OF LIFE; REVIEW; STROKE; SURGICAL TECHNIQUE; SURVIVAL; SURVIVAL RATE; TECHNOLOGY; TREATMENT INDICATION;

HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 80655144949     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2011.08.005     Document Type: Review

References (16)

1. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001, 345(20):1435-1443.
2. Slaughter M.S., Rogers J.G., Milano C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009, 361(23):2241-2251.
3. Rogers J.G., Butler J., Lansman S.L., et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 2007, 50(8):741-747.
4. Pae W.E., Connell J.M., Adelowo A., et al. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant 2007, 26(3):219-229.
5. Dowling R.D., Park S.J., Pagani F.D., et al. HeartMate VE LVAS design enhancements and its impact on device reliability. Eur J Cardiothorac Surg 2004, 25(6):958-963.
6. Lietz K., Long J.W., Kfoury A.G., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007, 116(5):497-505.
7. Farkas E., Elefteriades J. Assisted circulation: experience with the Novacor Left Ventricular Assist System. Expert Rev Med Devices 2007, 4:769-774.
8. Kirklin J.K., Naftel D.C., Kormos R.L., et al. Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant 2011, 30(2):115-123.
9. Kamdar F., Boyle A., Liao K., et al. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant 2009, 28(4):352-359.
10. Russell S.D., Roger J.G., Milano C.A., et al. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 2009, 120:2352-2357.
11. Petrucci R.J., Wright S., Naka Y., et al. Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices. J Heart Lung Transplant 2009, 28(6):542-549.
12. Pak S.W., Uriel N., Takayama H., et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant 2010, 29(10):1172-1176.
13. Cowger J., Pagani F.D., Haft J.W., et al. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail 2010, 3(6):668-674.
14. Uriel N., Pak S.W., Jorde U.P., et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010, 56(15):1207-1213.
15. Rao V., Oz M.C., Flannery M.A., et al. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 2003, 125(4):855-862.
16. Gracin N., Johnson M.R., Spokas D., et al. The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation. J Heart Lung Transplant 1998, 17(10):1017-1023.